The endogenous cannabinoid system in Individuals with opioid use disorder and healthy: A brain imaging study

The purpose of the study is to examine the endocannabinoid (eCB) function in individuals with Opioid Use Disorder (OUD) who take methadone or suboxone by measuring cannabinoid receptor 1 (CB1R) availability. Participation includes a screening visit, brain imaging sessions including MRI and PET scan, and two follow-up phone calls. Total estimated compensation is up to $550.

• Study Details | OMAR Opioid Use Disorder | ClinicalTrials.gov